These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33003164)

  • 1. Proton-pump Inhibitor Response Prediction Using Esophageal microRNAs in Children With Eosinophilic Esophagitis.
    Cañas JA; Tabares A; Barbero C; García-Sánchez D; Sastre B; Rodrigo-Muñoz JM; Mahíllo-Fernández I; Rayo A; Borrell B; Cilleruelo ML; Román E; Fernandez-Fernandez S; Gutiérrez-Junquera C; Del Pozo V
    J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):755-763. PubMed ID: 33003164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of filaggrin is decreased in proton pump inhibitor non-responders compared with proton pump inhibitor responders of eosinophilic esophagitis.
    Nagano N; Araki A; Ishikawa N; Nagase M; Adachi K; Ishimura N; Ishihara S; Kinoshita Y; Maruyama R
    Esophagus; 2021 Apr; 18(2):362-371. PubMed ID: 32909083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study.
    Dellon ES; Speck O; Woodward K; Covey S; Rusin S; Gebhart JH; Chen X; Woosley JT; Shaheen NJ
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2015-22. PubMed ID: 24993367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlapping Transcriptional Profile in Proton Pump Inhibitor Responsive and Nonresponsive Eosinophilic Esophagitis.
    Hamilton MJ; Muftah M; Goldin AH; Lo WK; Hsu Blatman KS; Chan WW; Srivastava A
    Clin Transl Gastroenterol; 2022 Nov; 13(11):e00540. PubMed ID: 36201660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophil-Derived Neurotoxin Predicts Response to Proton-Pump Inhibitor Treatment in Pediatric Eosinophilic Esophagitis.
    Irastorza LE; Hopson P; Nabar S; Deb C; Smadi Y
    J Pediatr Gastroenterol Nutr; 2022 Feb; 74(2):267-271. PubMed ID: 34321427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis.
    Mougey EB; Williams A; Coyne AJK; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Román E; González Lois C; Chao M; Al-Atrash H; Lima JJ; Franciosi JP
    J Pediatr Gastroenterol Nutr; 2019 Nov; 69(5):581-587. PubMed ID: 31490856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatment.
    Ugalde-Triviño L; Molina-Jiménez F; H-Vázquez J; Relaño-Rupérez C; Arias-González L; Casabona S; Pérez-Fernández MT; Martín-Domínguez V; Fernández-Pacheco J; Lucendo AJ; Bernardo D; Santander C; Majano P
    Front Immunol; 2024; 15():1374611. PubMed ID: 38646544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the clinical and allergy profiles of PPI responsive and non-responsive eosinophilic esophagitis.
    Goldin AH; Muftah M; Mangla S; Hornick JL; Hsu Blatman K; Hamilton MJ; Lo WK; Chan WW
    Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36567533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
    Jiao D; Ishimura N; Maruyama R; Ishikawa N; Nagase M; Oshima N; Aimi M; Okimoto E; Mikami H; Izumi D; Okada M; Ishihara S; Kinoshita Y
    J Gastroenterol; 2017 Feb; 52(2):203-210. PubMed ID: 27108416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of proton pump inhibitor therapy in the management of eosinophilic esophagitis.
    Molina-Infante J; Prados-Manzano R; Gonzalez-Cordero PL
    Expert Rev Clin Immunol; 2016 Sep; 12(9):945-52. PubMed ID: 27097787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor effect on esophageal protein signature of eosinophilic esophagitis, prediction, and evaluation of treatment response.
    Molina-Jiménez F; Ugalde-Triviño L; Arias-González L; Armenteros E; Relaño-Rupérez C; Casabona S; Moreno-Monteagudo JA; Pérez-Fernández MT; Martín-Domínguez V; Fernández-Pacheco J; Laserna-Mendieta EJ; Muñoz-Hernández P; García-Martínez J; Muñoz J; Lucendo AJ; Santander C; Majano P
    Allergy; 2024 Aug; ():. PubMed ID: 39092539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia.
    Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Quevedo S; Bracamonte T; Román E
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):704-10. PubMed ID: 26513622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
    Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
    Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression.
    Molina-Infante J; Rivas MD; Hernandez-Alonso M; Vinagre-Rodríguez G; Mateos-Rodríguez JM; Dueñas-Sadornil C; Perez-Gallardo B; Ferrando-Lamana L; Fernandez-Gonzalez N; Bañares R; Zamorano J
    Aliment Pharmacol Ther; 2014 Oct; 40(8):955-65. PubMed ID: 25112708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
    Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT6 Variants Associate With Relapse of Eosinophilic Esophagitis in Patients Receiving Long-term Proton Pump Inhibitor Therapy.
    Mougey EB; Nguyen V; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Borrell B; Román E; González-Lois C; Chao M; Al-Atrash H; Franciosi JP
    Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2046-2053.e2. PubMed ID: 32798708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic esophagitis in Japan: Focus on response to acid suppressive therapy.
    Ishimura N; Kinoshita Y
    J Gastroenterol Hepatol; 2018 May; 33(5):1016-1022. PubMed ID: 29278655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis.
    Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Borrell B; Román E
    J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):210-216. PubMed ID: 29509636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton-pump inhibitor-responsive esophageal eosinophilia.
    Molina-Infante J; Katzka DA
    Curr Opin Gastroenterol; 2014 Jul; 30(4):428-33. PubMed ID: 24837227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.